Favourable Tumour Marker Decline Following CBOP/BEP Chemotherapy in Poor Prognosis Testicular Patients Does Not Serve as a Predictor for Improved Progression-free Survival and Overall Survival

Mehta S.; Huddart R.

首页> 外文期刊>Clinical oncology >Favourable Tumour Marker Decline Following CBOP/BEP Chemotherapy in Poor Prognosis Testicular Patients Does Not Serve as a Predictor for Improved Progression-free Survival and Overall Survival

【24h】

Favourable Tumour Marker Decline Following CBOP/BEP Chemotherapy in Poor Prognosis Testicular Patients Does Not Serve as a Predictor for Improved Progression-free Survival and Overall Survival

机译：患CBOP / BEP化疗在较差的预后睾丸睾丸患者中的有利肿瘤标志物下降不作为改善无进展生存和整体生存的预测因素

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical oncology》 |2019年第2期|共5页
作者
Mehta S.; Huddart R.;
展开▼
作者单位

Royal Surrey Cty Hosp Guildford Surrey England;

Royal Marsden NHS Fdn Trust London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Favourable Tumour Marker Decline Following CBOP/BEP Chemotherapy in Poor Prognosis Testicular Patients Does Not Serve as a Predictor for Improved Progression-free Survival and Overall Survival [J] . Mehta S., Huddart R. Clinical oncology . 2019,第2期

机译：患CBOP / BEP化疗在较差的预后睾丸睾丸患者中的有利肿瘤标志物下降不作为改善无进展生存和整体生存的预测因素
2. A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604) [J] . Robert A. Huddart, Jeff D. White, Jonathan Shamash, Indian heart journal . 2015,第3期

机译：一种随机相2试验强化诱导化疗（CBOP / BEP）和标准BEP在差的预后细胞瘤中（MRC TE23，CRUK 05/014，ISRCTN 53643604）
3. Intensive Induction Chemotherapy With CBOP/BEP in Patients With Poor Prognosis Germ Cell Tumors. [J] . Christian JA, Huddart RA, Norman A, Journal of Clinical Oncology . 2003,第5期

机译：预后不良的生殖细胞肿瘤患者采用CBOP / BEP的密集诱导化学疗法。
4. Machine learning of patient similarity: A case study on predicting survival in cancer patient after locoregional chemotherapy [C] . 2010 IEEE International Conference on Bioinformatics and Biomedicine Workshops . 2010

机译：患者相似性的机器学习：预测局部化疗后癌症患者生存率的案例研究
5. A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23 CRUK 05/014 ISRCTN 53643604) [O] . Robert A. Huddart, Rhian Gabe, Fay H. Cafferty, -1

机译：预后不良的生殖细胞肿瘤的密集诱导化学疗法（CBOP / BEP）和标准BEP的随机2期试验（MRC TE23CRUK 05/014ISRCTN 53643604）
6. A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604) [O] . Huddart Robert A., Gabe Rhian, Cafferty Fay H., 2015

机译：预后不良的生殖细胞肿瘤的密集诱导化学疗法（CBOP / BEP）和标准BEP的随机2期试验（MRC TE23，CRUK 05/014，ISRCTN 53643604）

Favourable Tumour Marker Decline Following CBOP/BEP Chemotherapy in Poor Prognosis Testicular Patients Does Not Serve as a Predictor for Improved Progression-free Survival and Overall Survival

著录项

相似文献

相关主题

期刊订阅